Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer

Authors:	Karolina Edlund Miriam Lohr Karin Jirström Anders Berglund Johan Botling Jörg Rahnenfuehrer Millaray Marincevic Fredrik Pontén Simon Ekman Jan Hengstler Stefan Wöll Özlem Türeci

Affiliation:	1. Department of Immunology, Genetics and Pathology, Uppsala University, , Uppsala, Sweden;2. Leibniz Research Centre for Working Environment and Human Factors (IfADo) at TU Dortmund University, , Dortmund, Germany;3. Department of Statistics, TU Dortmund University, , Dortmund, Germany;4. Department. of Clinical Sciences, Division of Pathology, Lund University, Sk?ne University Hospital, , Lund, Sweden;5. Regional Cancer Center Uppsala‐?rebro, , Uppsala, Sweden;6. Department of Radiology, Oncology and Radiation Sciences, Section of Oncology, Uppsala University, , Uppsala, Sweden;7. Ganymed Pharmaceuticals AG, , Mainz, Germany

Abstract:

Keywords:	non‐small‐cell lung cancer targeted therapy gene expression profiling claudin tissue microarray